Sort
326,823 grants matching “clinical trial”
Evaluation of anal self-sampling in HIV men-who-have-sex-with-men (HIV MSM) populations
$2,714,016Megan Clarke · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Development of vaccines to bacterial diseases found especially in children
$2,713,785John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Shared Resource Management
$2,713,641Marcus E Peter · Northwestern University At Chicago · P30 · FY2025 · CA
Interrogating the molecular underpinnings of metastatic colonization
$2,713,636Jonathan Hernandez · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Center for Molecular Epidemiology
$2,713,622Margaret Rita Karagas · Dartmouth College · P20 · FY2013 · GM
Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma
$2,713,467Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,713,336Alison Morris · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · HL
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,713,014Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · HL
SPORE in Skin Cancer
$2,712,962Brigham And Women'S Hospital · P50 · FY2001 · CA
Regulatory Support for Cancer Prevention Agent Development
$2,712,613Caroline Sigman · Ccs Associates, Inc. · N02 · FY2019 · CA
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges
$2,712,362Michelle G Craske · University Of California Los Angeles · P50 · FY2025 · MH
HIV/AIDS Clinical Trials Unit
$2,712,311John A Bartlett · Duke University · U01 · FY2009 · AI
A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson's Disease
$2,712,004Aleksandar Videnovic · Massachusetts General Hospital · U01 · FY2019 · NS
Pediatric Brain Tumor Consortium (PBTC)
$2,711,850Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2018 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,711,483Pamela J Bjorkman · California Institute Of Technology · P01 · FY2020 · AI
Pediatric Brain Tumor Consortium (PBTC)
$2,711,401Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2016 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,710,901Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2017 · CA
Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis
$2,710,457George Louis Drusano · University Of Florida · P01 · FY2019 · AI
Personalized prime editing as a platform for hepatic inborn errors of metabolism
$2,710,325Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · U01 · FY2025 · TR
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
$2,710,272Joren C Madsen · Massachusetts General Hospital · U01 · FY2021 · AI
Food Effect study and drug supply scale-up for PTI-125
$2,710,220Lindsay H Burns · Cassava Sciences, Inc · R01 · FY2021 · AG
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$2,709,730Linda-Gail Bekker · University Of Cape Town · UM1 · FY2024 · AI
Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans
$2,709,545Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2014 · AI
COORDINATING CENTER FOR AMD PREVENTION TRIAL
$2,709,348University Of Pennsylvania · U10 · FY2001 · EY
ECOG Statistical Office Data Management Grant
$2,709,210Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2005 · CA